APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IL-4Rα Targeting Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global IL-4Rα Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174001670329 December 2025194 pages

Choose your research edition.

Industry ResearchIL-4Rα Targeting Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-4Rα Targeting Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal IL-4Rα Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-4Rα Targeting Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-4Rα Targeting Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global IL-4Rα Targeting Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for IL-4Rα Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IL-4Rα Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-4Rα Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for IL-4Rα Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-4Rα Targeting Drugs include AstraZeneca, Innovent Biologics, Numab Therapeutics, Regeneron, Sanofi, Hengrui Medical, Kengfang Biopharmaceuticals, Connaide Biopharmaceuticals and Conoya Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global IL-4Rα Targeting Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IL-4Rα Targeting Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IL-4Rα Targeting Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IL-4Rα Targeting Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

IL-4Rα Targeting Drugs Segment by Company

AstraZeneca

Innovent Biologics

Numab Therapeutics

Regeneron

Sanofi

Hengrui Medical

Kengfang Biopharmaceuticals

Connaide Biopharmaceuticals

Conoya Biopharmaceuticals

Qingzhixiang Jintai Biopharmaceuticals

Sunshine Guojian

IL-4Rα Targeting Drugs Segment by Type

Small Molecule Inhibitors

Fusion Proteins

Monoclonal Antibodies

Vaccines

IL-4Rα Targeting Drugs Segment by Application

Chronic Sinusitis with Nasal Polyps

Atopic Dermatitis

Asthma

Other

IL-4Rα Targeting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-4Rα Targeting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-4Rα Targeting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-4Rα Targeting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the IL-4Rα Targeting Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-4Rα Targeting Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of IL-4Rα Targeting Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of IL-4Rα Targeting Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. IL-4Rα Targeting Drugs Industry Trends Table 2. IL-4Rα Targeting Drugs Industry Drivers Table 3. IL-4Rα Targeting Drugs Industry Opportunities and Challenges Table 4. IL-4Rα Targeting Drugs Industry Restraints Table 5. Global IL-4Rα Targeting Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global IL-4Rα Targeting Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global IL-4Rα Targeting Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global IL-4Rα Targeting Drugs Sales Market Share by Manufacturers Table 9. Global IL-4Rα Targeting Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global IL-4Rα Targeting Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global IL-4Rα Targeting Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global IL-4Rα Targeting Drugs Manufacturers, Product Type & Application Table 13. Global IL-4Rα Targeting Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global IL-4Rα Targeting Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Small Molecule Inhibitors Table 17. Major Manufacturers of Fusion Proteins Table 18. Major Manufacturers of Monoclonal Antibodies Table 19. Major Manufacturers of Vaccines Table 20. Global IL-4Rα Targeting Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global IL-4Rα Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 22. Global IL-4Rα Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 23. Global IL-4Rα Targeting Drugs Sales Market Share by Type (2021-2026) Table 24. Global IL-4Rα Targeting Drugs Sales Market Share by Type (2027-2032) Table 25. Global IL-4Rα Targeting Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global IL-4Rα Targeting Drugs Revenue by Type (2021-2026) & (K Units) Table 27. Global IL-4Rα Targeting Drugs Revenue by Type (2027-2032) & (K Units) Table 28. Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2021-2026) Table 29. Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Chronic Sinusitis with Nasal Polyps Table 31. Major Manufacturers of Atopic Dermatitis Table 32. Major Manufacturers of Asthma Table 33. Major Manufacturers of Other Table 34. Global IL-4Rα Targeting Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global IL-4Rα Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global IL-4Rα Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global IL-4Rα Targeting Drugs Sales Market Share by Application (2021-2026) Table 38. Global IL-4Rα Targeting Drugs Sales Market Share by Application (2027-2032) Table 39. Global IL-4Rα Targeting Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global IL-4Rα Targeting Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global IL-4Rα Targeting Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2021-2026) Table 43. Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2027-2032) Table 44. Global IL-4Rα Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global IL-4Rα Targeting Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global IL-4Rα Targeting Drugs Sales Market Share by Region (2021-2026) Table 47. Global IL-4Rα Targeting Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global IL-4Rα Targeting Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America IL-4Rα Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America IL-4Rα Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe IL-4Rα Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe IL-4Rα Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific IL-4Rα Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific IL-4Rα Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global IL-4Rα Targeting Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global IL-4Rα Targeting Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global IL-4Rα Targeting Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global IL-4Rα Targeting Drugs Revenue Market Share by Region (2021-2026) Table 65. Global IL-4Rα Targeting Drugs Revenue Market Share by Region (2027-2032) Table 66. AstraZeneca Company Information Table 67. AstraZeneca Business Overview Table 68. AstraZeneca IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. AstraZeneca IL-4Rα Targeting Drugs Product Portfolio Table 70. AstraZeneca Recent Development Table 71. Innovent Biologics Company Information Table 72. Innovent Biologics Business Overview Table 73. Innovent Biologics IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Innovent Biologics IL-4Rα Targeting Drugs Product Portfolio Table 75. Innovent Biologics Recent Development Table 76. Numab Therapeutics Company Information Table 77. Numab Therapeutics Business Overview Table 78. Numab Therapeutics IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Numab Therapeutics IL-4Rα Targeting Drugs Product Portfolio Table 80. Numab Therapeutics Recent Development Table 81. Regeneron Company Information Table 82. Regeneron Business Overview Table 83. Regeneron IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Regeneron IL-4Rα Targeting Drugs Product Portfolio Table 85. Regeneron Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sanofi IL-4Rα Targeting Drugs Product Portfolio Table 90. Sanofi Recent Development Table 91. Hengrui Medical Company Information Table 92. Hengrui Medical Business Overview Table 93. Hengrui Medical IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Hengrui Medical IL-4Rα Targeting Drugs Product Portfolio Table 95. Hengrui Medical Recent Development Table 96. Kengfang Biopharmaceuticals Company Information Table 97. Kengfang Biopharmaceuticals Business Overview Table 98. Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio Table 100. Kengfang Biopharmaceuticals Recent Development Table 101. Connaide Biopharmaceuticals Company Information Table 102. Connaide Biopharmaceuticals Business Overview Table 103. Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio Table 105. Connaide Biopharmaceuticals Recent Development Table 106. Conoya Biopharmaceuticals Company Information Table 107. Conoya Biopharmaceuticals Business Overview Table 108. Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio Table 110. Conoya Biopharmaceuticals Recent Development Table 111. Qingzhixiang Jintai Biopharmaceuticals Company Information Table 112. Qingzhixiang Jintai Biopharmaceuticals Business Overview Table 113. Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio Table 115. Qingzhixiang Jintai Biopharmaceuticals Recent Development Table 116. Sunshine Guojian Company Information Table 117. Sunshine Guojian Business Overview Table 118. Sunshine Guojian IL-4Rα Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Sunshine Guojian IL-4Rα Targeting Drugs Product Portfolio Table 120. Sunshine Guojian Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. IL-4Rα Targeting Drugs Distributors List Table 124. IL-4Rα Targeting Drugs Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. IL-4Rα Targeting Drugs Product Image Figure 2. Global IL-4Rα Targeting Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-4Rα Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-4Rα Targeting Drugs Sales (2021-2032) & (K Units) Figure 5. Global IL-4Rα Targeting Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 IL-4Rα Targeting Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Small Molecule Inhibitors Image Figure 9. Fusion Proteins Image Figure 10. Monoclonal Antibodies Image Figure 11. Vaccines Image Figure 12. Global IL-4Rα Targeting Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global IL-4Rα Targeting Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global IL-4Rα Targeting Drugs Sales Market Share by Type (2021-2032) Figure 15. Global IL-4Rα Targeting Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global IL-4Rα Targeting Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2021-2032) Figure 18. Chronic Sinusitis with Nasal Polyps Image Figure 19. Atopic Dermatitis Image Figure 20. Asthma Image Figure 21. Other Image Figure 22. Global IL-4Rα Targeting Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global IL-4Rα Targeting Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global IL-4Rα Targeting Drugs Sales Market Share by Application (2021-2032) Figure 25. Global IL-4Rα Targeting Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global IL-4Rα Targeting Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America IL-4Rα Targeting Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe IL-4Rα Targeting Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific IL-4Rα Targeting Drugs Sales Market Share by Country (2021-2032) Figure 42. China IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa IL-4Rα Targeting Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile IL-4Rα Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global IL-4Rα Targeting Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global IL-4Rα Targeting Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America IL-4Rα Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe IL-4Rα Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific IL-4Rα Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa IL-4Rα Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. IL-4Rα Targeting Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. IL-4Rα Targeting Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule Inhibitors
  • Fusion Proteins
  • Monoclonal Antibodies
  • Vaccines
Applications
  • Chronic Sinusitis with Nasal Polyps
  • Atopic Dermatitis
  • Asthma
  • Other
Companies covered
  • AstraZeneca
  • Innovent Biologics
  • Numab Therapeutics
  • Regeneron
  • Sanofi
  • Hengrui Medical
  • Kengfang Biopharmaceuticals
  • Connaide Biopharmaceuticals
  • Conoya Biopharmaceuticals
  • Qingzhixiang Jintai Biopharmaceuticals
  • Sunshine Guojian

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IL-4Rα Targeting Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IL-4Rα Targeting Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global IL-4Rα Targeting Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global IL-4Rα Targeting Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global IL-4Rα Targeting Drugs Market Dynamics
  1. 2.1 IL-4Rα Targeting Drugs Industry Trends
  2. 2.2 IL-4Rα Targeting Drugs Industry Drivers
  3. 2.3 IL-4Rα Targeting Drugs Industry Opportunities and Challenges
  4. 2.4 IL-4Rα Targeting Drugs Industry Restraints
3 IL-4Rα Targeting Drugs Market by Manufacturers
  1. 3.1 Global IL-4Rα Targeting Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global IL-4Rα Targeting Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global IL-4Rα Targeting Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global IL-4Rα Targeting Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-4Rα Targeting Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global IL-4Rα Targeting Drugs Manufacturers, Product Type & Application
  7. 3.7 Global IL-4Rα Targeting Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-4Rα Targeting Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-4Rα Targeting Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-4Rα Targeting Drugs Tier 1, Tier 2, and Tier 3
4 IL-4Rα Targeting Drugs Market by Type
  1. 4.1 IL-4Rα Targeting Drugs Type Introduction
  2. 4.1.1 Small Molecule Inhibitors
  3. 4.1.2 Fusion Proteins
  4. 4.1.3 Monoclonal Antibodies
  5. 4.1.4 Vaccines
  6. 4.2 Global IL-4Rα Targeting Drugs Sales by Type
  7. 4.2.1 Global IL-4Rα Targeting Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global IL-4Rα Targeting Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global IL-4Rα Targeting Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global IL-4Rα Targeting Drugs Revenue by Type
  11. 4.3.1 Global IL-4Rα Targeting Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global IL-4Rα Targeting Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2021-2032)
5 IL-4Rα Targeting Drugs Market by Application
  1. 5.1 IL-4Rα Targeting Drugs Application Introduction
  2. 5.1.1 Chronic Sinusitis with Nasal Polyps
  3. 5.1.2 Atopic Dermatitis
  4. 5.1.3 Asthma
  5. 5.1.4 Other
  6. 5.2 Global IL-4Rα Targeting Drugs Sales by Application
  7. 5.2.1 Global IL-4Rα Targeting Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global IL-4Rα Targeting Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global IL-4Rα Targeting Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global IL-4Rα Targeting Drugs Revenue by Application
  11. 5.3.1 Global IL-4Rα Targeting Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global IL-4Rα Targeting Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2021-2032)
6 Global IL-4Rα Targeting Drugs Sales by Region
  1. 6.1 Global IL-4Rα Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IL-4Rα Targeting Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global IL-4Rα Targeting Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global IL-4Rα Targeting Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America IL-4Rα Targeting Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe IL-4Rα Targeting Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific IL-4Rα Targeting Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa IL-4Rα Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global IL-4Rα Targeting Drugs Revenue by Region
  1. 7.1 Global IL-4Rα Targeting Drugs Revenue by Region
  2. 7.1.1 Global IL-4Rα Targeting Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global IL-4Rα Targeting Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global IL-4Rα Targeting Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global IL-4Rα Targeting Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America IL-4Rα Targeting Drugs Revenue (2021-2032)
  8. 7.2.2 North America IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe IL-4Rα Targeting Drugs Revenue (2021-2032)
  11. 7.3.2 Europe IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific IL-4Rα Targeting Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa IL-4Rα Targeting Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa IL-4Rα Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca IL-4Rα Targeting Drugs Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Innovent Biologics
  8. 8.2.1 Innovent Biologics Company Information
  9. 8.2.2 Innovent Biologics Business Overview
  10. 8.2.3 Innovent Biologics IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Innovent Biologics IL-4Rα Targeting Drugs Product Portfolio
  12. 8.2.5 Innovent Biologics Recent Developments
  13. 8.3 Numab Therapeutics
  14. 8.3.1 Numab Therapeutics Company Information
  15. 8.3.2 Numab Therapeutics Business Overview
  16. 8.3.3 Numab Therapeutics IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Numab Therapeutics IL-4Rα Targeting Drugs Product Portfolio
  18. 8.3.5 Numab Therapeutics Recent Developments
  19. 8.4 Regeneron
  20. 8.4.1 Regeneron Company Information
  21. 8.4.2 Regeneron Business Overview
  22. 8.4.3 Regeneron IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Regeneron IL-4Rα Targeting Drugs Product Portfolio
  24. 8.4.5 Regeneron Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi IL-4Rα Targeting Drugs Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Hengrui Medical
  32. 8.6.1 Hengrui Medical Company Information
  33. 8.6.2 Hengrui Medical Business Overview
  34. 8.6.3 Hengrui Medical IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medical IL-4Rα Targeting Drugs Product Portfolio
  36. 8.6.5 Hengrui Medical Recent Developments
  37. 8.7 Kengfang Biopharmaceuticals
  38. 8.7.1 Kengfang Biopharmaceuticals Company Information
  39. 8.7.2 Kengfang Biopharmaceuticals Business Overview
  40. 8.7.3 Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
  42. 8.7.5 Kengfang Biopharmaceuticals Recent Developments
  43. 8.8 Connaide Biopharmaceuticals
  44. 8.8.1 Connaide Biopharmaceuticals Company Information
  45. 8.8.2 Connaide Biopharmaceuticals Business Overview
  46. 8.8.3 Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
  48. 8.8.5 Connaide Biopharmaceuticals Recent Developments
  49. 8.9 Conoya Biopharmaceuticals
  50. 8.9.1 Conoya Biopharmaceuticals Company Information
  51. 8.9.2 Conoya Biopharmaceuticals Business Overview
  52. 8.9.3 Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
  54. 8.9.5 Conoya Biopharmaceuticals Recent Developments
  55. 8.10 Qingzhixiang Jintai Biopharmaceuticals
  56. 8.10.1 Qingzhixiang Jintai Biopharmaceuticals Company Information
  57. 8.10.2 Qingzhixiang Jintai Biopharmaceuticals Business Overview
  58. 8.10.3 Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
  60. 8.10.5 Qingzhixiang Jintai Biopharmaceuticals Recent Developments
  61. 8.11 Sunshine Guojian
  62. 8.11.1 Sunshine Guojian Company Information
  63. 8.11.2 Sunshine Guojian Business Overview
  64. 8.11.3 Sunshine Guojian IL-4Rα Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sunshine Guojian IL-4Rα Targeting Drugs Product Portfolio
  66. 8.11.5 Sunshine Guojian Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 IL-4Rα Targeting Drugs Value Chain Analysis
  2. 9.1.1 IL-4Rα Targeting Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 IL-4Rα Targeting Drugs Production Mode & Process
  6. 9.2 IL-4Rα Targeting Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 IL-4Rα Targeting Drugs Distributors
  9. 9.2.3 IL-4Rα Targeting Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst